IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Business Wire
Partnership Aims to Accelerate NGS Adoption for Clinical Infectious Disease Testing by Combining Comprehensive Sequencing Workflows with Turn-key Clinical Informatics SAN FRANCISCO--(BUSINESS WIRE)--IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, today announced a global strategic partnership with Illumina, Inc. (Nasdaq: ILMN), to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market.Under the terms of the agreement, Illumina and IDbyDNA will each co-market IDbyDNA’s Explify® Platform for use with Illumina’s NGS systems and library preparation to provide a complete, streamlined workflow solution for infectious disease applications. In addition, IDbyDNA and Illumina will partner to co-develop research use only (RUO) workflows.The partnership aims to enable broad distribution of NGS equipment, library prep, as well as o
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Stephens from $170.00 to $184.00. They now have an "overweight" rating on the stock.MarketBeat
- Illumina, Inc. (NASDAQ: ILMN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $156.00 price target on the stock.MarketBeat
- Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics [Yahoo! Finance]Yahoo! Finance
- Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Piper Sandler from $195.00 to $185.00. They now have an "overweight" rating on the stock.MarketBeat
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 11/12/24 - Form SC
- 11/7/24 - Form 4
- 11/7/24 - Form 4
- ILMN's page on the SEC website